| Attribute |
Value |
| 52 Week Change |
-0.13132137 |
| Address1 |
60 rue de Wattignies |
| All Time High |
57.14 |
| All Time Low |
1.75 |
| Ask |
21.51 |
| Ask Size |
1 |
| Average Daily Volume10 Day |
138,260 |
| Average Daily Volume3 Month |
150,248 |
| Average Volume |
150,248 |
| Average Volume10Days |
138,260 |
| Beta |
0.591 |
| Bid |
21.27 |
| Bid Size |
1 |
| Book Value |
-0.7384023 |
| City |
Paris |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
France |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
21.3 |
| Current Ratio |
1.437 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
22.19 |
| Day Low |
21.27 |
| Display Name |
Nanobiotix |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,775,044,800 |
| Earnings Call Timestamp Start |
1,775,044,800 |
| Earnings Timestamp End |
1,790,712,000 |
| Earnings Timestamp Start |
1,790,712,000 |
| Ebitda |
-29,786,000 |
| Ebitda Margins |
-2.5887399 |
| Enterprise To Ebitda |
-36.186 |
| Enterprise To Revenue |
93.676 |
| Enterprise Value |
1,077,835,904 |
| Eps Current Year |
-0.54088 |
| Eps Forward |
-0.16779827 |
| Eps Trailing Twelve Months |
-1.27 |
| Esg Populated |
0 |
| Exchange |
NMS |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
34.6562 |
| Fifty Day Average Change |
-13.356201 |
| Fifty Day Average Change Percent |
-0.38539138 |
| Fifty Two Week Change Percent |
-13.132137 |
| Fifty Two Week High |
57.14 |
| Fifty Two Week High Change |
-35.84 |
| Fifty Two Week High Change Percent |
-0.62723136 |
| Fifty Two Week Low |
14.78 |
| Fifty Two Week Low Change |
6.5199995 |
| Fifty Two Week Low Change Percent |
0.44113666 |
| Fifty Two Week Range |
14.78 - 57.14 |
| Financial Currency |
EUR |
| First Trade Date Milliseconds |
1,607,697,000,000 |
| Float Shares |
35,148,446 |
| Forward Eps |
-0.16779827 |
| Forward P E |
-126.93813 |
| Free Cashflow |
-32,782,250 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
98 |
| Fullday Change |
-0.9300003 |
| Fullday Change Percent |
-4.1797767 |
| Fullday Price |
21.3 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
1.0 |
| Gross Profits |
11,506,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.11951999 |
| Implied Shares Outstanding |
50,919,410 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,020-12-11 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. |
| Long Name |
Nanobiotix S.A. |
| Market |
us_market |
| Market Cap |
1,084,583,296 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_20950715 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-52,866,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
1,762,673,651 |
| Number Of Analyst Opinions |
3 |
| Open |
22.19 |
| Operating Cashflow |
-34,186,000 |
| Operating Margins |
-3.22879 |
| Phone |
33 1 40 26 04 70 |
| Previous Close |
22.23 |
| Price Eps Current Year |
-39.380264 |
| Price Hint |
2 |
| Price To Book |
-28.846064 |
| Price To Sales Trailing12 Months |
94.26241 |
| Profit Margins |
0.0 |
| Quick Ratio |
1.399 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.93 |
| Regular Market Change Percent |
-4.18354 |
| Regular Market Day High |
22.19 |
| Regular Market Day Low |
21.27 |
| Regular Market Day Range |
21.27 - 22.19 |
| Regular Market Open |
22.19 |
| Regular Market Previous Close |
22.23 |
| Regular Market Price |
21.3 |
| Regular Market Time |
1,792,180,800 |
| Regular Market Volume |
77,771 |
| Return On Assets |
-0.21339001 |
| Revenue Growth |
-0.792 |
| Revenue Per Share |
0.237 |
| Sand P52 Week Change |
0.13723719 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
50,919,410 |
| Shares Percent Shares Out |
0.0029 |
| Shares Short |
146,868 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
149,217 |
| Short Name |
Nanobiotix S.A. |
| Short Percent Of Float |
0.0039 |
| Short Ratio |
1.1 |
| Source Interval |
15 |
| Symbol |
NBTX |
| Target High Price |
69.22091 |
| Target Low Price |
29.595278 |
| Target Mean Price |
54.034477 |
| Target Median Price |
63.287235 |
| Total Cash |
110,891,000 |
| Total Cash Per Share |
2.183 |
| Total Debt |
106,611,000 |
| Total Revenue |
11,506,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.27 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
33.4287 |
| Two Hundred Day Average Change |
-12.1287 |
| Two Hundred Day Average Change Percent |
-0.36282298 |
| Type Disp |
Equity |
| Volume |
77,771 |
| Website |
https://www.nanobiotix.com |
| Zip |
75,012 |